Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Anker

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Zeitschrift Fur Kardiologie|June 21, 2016
Chronic heart failure and cardiac cachexia and links between the endocrine and immune systemsS D Anker, M Cicoira
Heart (British Cardiac Society)|May 17, 2005
Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?W Doehner, S D Anker
International Journal of Cardiology|November 26, 1999
Cardiac cachexia is a world-wide problemR Sharma, S D Anker
The American Journal of Cardiology|September 25, 1999
Insulin-mediated glucose uptake in congestive heart failureW Doehner, S D Anker
Journal of the American College of Cardiology|July 14, 2001
Lean tissue adjusted peak oxygen consumption in congestive heart failureR Wensel, S D Anker
Clinical Pharmacology and Therapeutics|June 10, 2011
The obesity paradox in heart failure: accepting reality and making rational decisionsS D Anker, S von Haehling
Drugs|January 11, 2001
Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implicationsA P Bolger, S D Anker
European Heart Journal|March 31, 1998
Cachexia in heart failure is bad for youS D Anker, A J Coats
Heart (British Cardiac Society)|December 18, 2004
Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?S von Haehling, S D Anker
Chest|March 20, 1999
Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activationS D Anker, A J Coats
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Zeitschrift Fur Kardiologie|June 21, 2016
Chronic heart failure and cardiac cachexia and links between the endocrine and immune systemsS D Anker, M Cicoira
Heart (British Cardiac Society)|May 17, 2005
Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?W Doehner, S D Anker
International Journal of Cardiology|November 26, 1999
Cardiac cachexia is a world-wide problemR Sharma, S D Anker
The American Journal of Cardiology|September 25, 1999
Insulin-mediated glucose uptake in congestive heart failureW Doehner, S D Anker
Journal of the American College of Cardiology|July 14, 2001
Lean tissue adjusted peak oxygen consumption in congestive heart failureR Wensel, S D Anker
Clinical Pharmacology and Therapeutics|June 10, 2011
The obesity paradox in heart failure: accepting reality and making rational decisionsS D Anker, S von Haehling
Drugs|January 11, 2001
Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implicationsA P Bolger, S D Anker
European Heart Journal|March 31, 1998
Cachexia in heart failure is bad for youS D Anker, A J Coats
Heart (British Cardiac Society)|December 18, 2004
Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?S von Haehling, S D Anker
Chest|March 20, 1999
Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activationS D Anker, A J Coats
Pageof 12